ArticleAmerican journal of translational research2021
Development of a random forest model to classify sarcoidosis and tuberculosis.
Article in American journal of translational research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.
- Performance of Serum Angiotensin-Converting Enzyme in Diagnosing Sarcoidosis and Predicting the Active Status of Sarcoidosis: A Meta-Analysis.Biomolecules · 2022Pooled it
- A transcriptomic signature that predicts prehypertension in adolescence and higher systolic blood pressure in childhood.JCI insight · 2025Article
- Integration of AI and ML in Tuberculosis (TB) Management: From Diagnosis to Drug Discovery.Diseases (Basel, Switzerland) · 2025Review
- Differential Diagnosis of Tuberculosis and Sarcoidosis by Immunological Features Using Machine Learning.Diagnostics (Basel, Switzerland) · 2024Article
- The Inflammatory State of Follicular Fluid Combined with Negative Emotion Indicators can Predict Pregnancy Outcomes in Patients with PCOS.Reproductive sciences (Thousand Oaks, Calif.) · 2024Article
- Construction of an auxiliary scoring model for myelosuppression in patients with lung cancer chemotherapy based on random forest algorithm.American journal of translational research · 2023Article
- Reliable Sarcoidosis Detection Using Chest X-rays with EfficientNets and Stain-Normalization Techniques.Sensors (Basel, Switzerland) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo identify significant diagnostic factors and establish a predictive model for diagnosis of sarcoidosis and tuberculosis.
methodsThis study included 252 patients (123 cases of lung sarcoidosis and 129 cases of lung tuberculosis) who underwent laboratory evaluation, including routine hematologic testing, serum immunology, blood coagulation, angiotensin-converting enzyme, and T lymphocyte subset. The factors that statistically different between the two groups were identified by an independent sample t test first, and then processed by the random forest model to distinguish two diseases with the classification function. Moreover, the diagnostic performance of the predictive random forest model was evaluated through the identification of individual contribution of various diagnostic factors conducted by the model.
resultsThe random forest model revealed a classification error rate of 24.9%. Among all of the statistically significant diagnostic factors, the individual factors with the greatest and second contribution were angiotensin-converting enzyme and prothrombin time, respectively. The area under the receiver operating characteristic (ROC) curve of the random forest prediction model was 0.915.
conclusionThe random forest model can be used to distinguish between sarcoidosis and tuberculosis by incorporating statistically significant diagnostic factors, which is of potential clinical application value.
Indexed as
Identifiers
34306355PMC8290672W3187058925What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.